Thomas DeLeon

Affiliations

Division of Hematology/Oncology, Mayo Clinic, Phoenix, AZ, USA.

Publications (1)

A pilot study of Pan-FGFR inhibitor ponatinib in patients with FGFR-altered advanced cholangiocarcinoma.

Investigational new drugs

Avec: Daniel H Ahn , Pedro Luiz Serrano Uson Junior , Peter Masci , Heidi Kosiorek , Thorvardur R Halfdanarson , Kabir Mody , Hani Babiker , Thomas DeLeon , Mohamad Bassam Sonbol , Gregory Gores , Rory Smoot , Tanios Bekaii-Saab , Amit Mahipal , Aaron Mansfield , Nguyen H Tran , Joleen M Hubbard , Mitesh J Borad

Réseau de co-auteurs

Daniel H Ahn 1 collaboration

Pedro Luiz Serrano Uson Junior 1 collaboration

Peter Masci 1 collaboration

Heidi Kosiorek 1 collaboration

Thorvardur R Halfdanarson 1 collaboration

Kabir Mody 1 collaboration

Hani Babiker 1 collaboration

Mohamad Bassam Sonbol 1 collaboration

Gregory Gores 1 collaboration

Rory Smoot 1 collaboration

Tanios Bekaii-Saab 1 collaboration

Amit Mahipal 1 collaboration

Aaron Mansfield 1 collaboration

Nguyen H Tran 1 collaboration

Joleen M Hubbard 1 collaboration

Mitesh J Borad 1 collaboration